Entyvio (Vedolizumab) Long-Term Safety Study: An International Observational Prospective Cohort Study Comparing Vedolizumab to Other Biologic Agents in Patients with Ulcerative Colitis or Crohn's Disease | Dartmouth-Hitchcock
Skip to main content
x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
Entyvio (Vedolizumab) Long-Term Safety Study: An International Observational Prospective Cohort Study Comparing Vedolizumab to Other Biologic Agents in Patients with Ulcerative Colitis or Crohn's Disease
Principal Investigator (?)
Study Number
F15191
Summary
The purpose of this study is to assess the long-term safety of vedolizumab versus other biologic agents in participants with Ulcerative Colitis (UC) or Crohn''s Disease (CD). 
Phase (?)
Phase III
Sponsor (?)
Contact

Anna Haron

Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0